B. Sorbe

B. Sorbe, P. Lannes, 1986, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies.

P. Zola, A. Lissoni, S. Grénman, 2010, European journal of cancer.

Prognostic factors for surgical outcome and survival in 447 women treated for advanced (FIGO-stages III-IV) epithelial ovarian carcinoma.

I. Skirnisdottir, B. Sorbe, 2007, International journal of oncology.

Determination of the most effective cooling temperature for the prevention of chemotherapy-induced alopecia.

A. Gustafsson, B. Sorbe, Lisa Nygren, 2013, Molecular and clinical oncology.

Active Pharmacologic Management of the Third Stage of Labor: A Comparison of Oxytocin and Ergometrine

B. Sorbe, 1978, Obstetrics and gynecology.

Genetic Alterations in the K-Ras Gene Influence the Prognosis in Patients With Cervical Cancer Treated by Radiotherapy

C. Ahlin, P. Wegman, B. Sorbe, 2010, International Journal of Gynecologic Cancer.

external beam radiation therapy alone in the treatment of cervical cancer a single institution study on efficacy and safety

B. Sorbe, Louise Bohr Mordhorst, A. Dreifaldt, 2019 .

DNA ploidy, morphometry, and nuclear grade as prognostic factors in endometrial carcinoma.

B. Sorbe, B. Risberg, B. Frankendal, 1990, Gynecologic oncology.

Prognostic impact of human papilloma virus (HPV) genotyping and HPV-16 subtyping in vaginal carcinoma.

B. Sorbe, M. Karlsson, G. Helenius, 2013, Gynecologic oncology.

Lived experiences of women with recurring ovarian cancer.

B. Ternestedt, H. Sunvisson, B. Sorbe, 2014, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel–irinotecan as first-line therapy for ovarian cancer

G. Jayson, D. Cruickshank, P. Wilkinson, 2005, British Journal of Cancer.

Prognostic importance of the time interval from surgery to chemotherapy in treatment of ovarian carcinoma

B. Sorbe, 2003, International Journal of Gynecologic Cancer.

Quality Indicators and Survival Outcome in Stage IIIB-IVB Epithelial Ovarian Cancer Treated at a Single Institution

B. Sorbe, K. Jansson, Inga Steinberga, 2019, In Vivo.

Early postpartum insertion of copper IUD.

B. Sorbe, L. Hagbard, C. Ingemanson, 1978, Contraception.

Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. The Nordic Antiemetic Trial Group.

O. Hansen, T. Högberg, B. Glimelius, 1995, Anti-Cancer Drugs.

Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin.

T. Högberg, B. Sorbe, A. Himmelmann, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.

B. Sorbe, 1994, Seminars in oncology.

Fever, haemoglobin and smoking as prognostic factors during the treatment of cervical carcinoma by radiotherapy.

B. Sorbe, O. Solberger, 1990, European journal of gynaecological oncology.

Intracavitary irradiation of prostatic carcinoma by a high dose-rate afterloading technique.

J. Johansson, B. Sorbe, D. Bernshaw, 1991, Acta oncologica.

Consolidation treatment of advanced ovarian carcinoma with radiotherapy after induction chemotherapy

B. Sorbe, 2003, International Journal of Gynecologic Cancer.

Patients' perceptions of communication with the health care team during chemotherapy for the first recurrence of ovarian cancer.

U. H. Graneheim, B. Ternestedt, B. Sorbe, 2011, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel— long- term follow- up

H. Andersson, P. Rosenberg, B. Sorbe, 2007, International Journal of Gynecologic Cancer.

Importance of Histologic Grading in the Prognosis of Epithelial Ovarian Carcinoma

B. Veress, B. Sorbe, B. Frankendal, 1982, Obstetrics and gynecology.

Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: A randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment

B. Sorbe, 2003, International Journal of Gynecologic Cancer.

Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinoma.

E. D. de Vries, B. Kiese, H. Meden, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma

T. Seidal, I. Skirnisdottir, B. Sorbe, 2000, International Journal of Gynecologic Cancer.

A Systematic Overview of Radiation Therapy Effects in Cervical Cancer (Cervix Uteri)

C. Tropé, E. Cavallin-ståhl, N. Einhorn†, 2003, Acta oncologica.

Prophylactic inguinal-femoral irradiation as an alternative to primary lymphadenectomy in treatment of vulvar carcinoma.

B. Sorbe, S. Hallak, Luz Ladi, 2007, International journal of oncology.

A Systematic Overview of Radiation Therapy Effects in Ovarian Cancer

C. Tropé, E. Cavallin-ståhl, N. Einhorn†, 2003, Acta oncologica.

External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.

H. Andersson, G. Horvath, B. Sorbe, 2012, International journal of radiation oncology, biology, physics.

Preoperative intracavitary irradiation of endometrial carcinoma stage I by a high dose rate afterloading technique.

B. Sorbe, B. Risberg, B. Frankendal, 1989, Acta oncologica.

Section Review: Central & Peripheral Nervous Systems: 5-HT3 receptor antagonists as antiemetic agents in cancer chemotherapy

B. Sorbe, 1996 .

A population-based series of uterine carcinosarcomas with long-term follow-up

G. Steineck, B. Sorbe, S. Andersson, 2013, Acta oncologica.

HPV16 viral characteristics in primary, recurrent and metastatic vulvar carcinoma

B. Sorbe, M. Karlsson, G. Helenius, 2018, Papillomavirus research.

Human Papillomavirus (HPV) and HPV 16–Variant Distribution in Vulvar Squamous Cell Carcinoma in Sweden

F. Elgh, B. Sorbe, M. Karlsson, 2012, International Journal of Gynecologic Cancer.

An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramidecontaining antiemetic cocktail in the prevention of cisplatin-induced emesis

B. Sorbe, B. Frankendal, C. Hallén, 2004, Cancer Chemotherapy and Pharmacology.

Tropisetron, a New 5-HT3-Receptor Antagonist, in the Prevention of Radiation-Induced Nausea, Vomiting and Diarrhoea

B. Sorbe, A. Berglind, 2012, Drugs.

Tropisetron, a new 5-HT3 receptor antagonist, in the prevention of radiation-induced emesis.

B. Sorbe, A. Berglind, K. D. de Bruijn, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-Risk Endometrial Carcinoma: A Prospective, Randomized Study—Quality-of-Life Analysis

H. Andersson, G. Horvath, B. Sorbe, 2012, International Journal of Gynecologic Cancer.

A clinical evaluation of the CRE system in adjunctive postoperative radiation treatment of ovarian carcinoma.

B. Sorbe, B. Frankendal, J. E. Persson, 1981, Gynecologic oncology.

Viral Load, Integration and Methylation of E2BS3 and 4 in Human Papilloma Virus (HPV) 16-Positive Vaginal and Vulvar Carcinomas

B. Sorbe, M. Karlsson, G. Helenius, 2014, PloS one.

Intravaginal Brachytherapy in FIGO Stage I Low-Risk Endometrial Cancer: A Controlled Randomized Study

J. Delaloye, B. Sorbe, D. Kuhelj, 2009, International Journal of Gynecologic Cancer.

Intravaginal high-dose-rate brachytherapy for stage I endometrial cancer: a randomized study of two dose-per-fraction levels.

B. Sorbe, L. Karlsson, A. Straumits, 2005, International Journal of Radiation Oncology, Biology, Physics.

Combined external pelvic chemoradiotherapy and image-guided adaptive brachytherapy in treatment of advanced cervical carcinoma: experience from a single institution

B. Sorbe, L. Karlsson, Louise Bohr Mordhorst, 2020, Journal of contemporary brachytherapy.

The prognostic value of a histologic grading system, DNA profile, and MIB-1 expression in early stages of cervical squamous cell carcinomas

M. Bryne, B. Sorbe, M. Karlsson, 2001, International Journal of Gynecologic Cancer.

Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting — the Nordic experience

M. Overgaard, M. Söderberg, T. Högberg, 1994, Supportive Care in Cancer.

A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum‐induced nausea and emesis

T. Högberg, H. Andersson, B. Sorbe, 1998, Cancer.

Tropisetron in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience.

B. Sorbe, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Immunohistochemical expression of p53, bcl-2, and p21(WAF1/CIP1) in early cervical carcinoma: correlation with clinical outcome.

B. Sorbe, M. Karlsson, M. Graflund, 2002, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Immunohistochemical expression of p53, bcl-2, and p21WAF1/CIP1 in early cervical carcinoma: Correlation with clinical outcome

B. Sorbe, M. Karlsson, M. Graflund, 2002, International Journal of Gynecologic Cancer.

A randomized phase-III study on adjuvant treatment with radiation (RT) {+/-} chemotherapy (CT) in early-stage high-risk endometrial cancer (NSGO-EC-9501/EORTC 55991)

G. Kristensen, T. Högberg, N. Reed, 2007 .

Lymph node sampling is of prognostic value in early stage epithelial ovarian carcinoma.

I. Skirnisdottir, B. Sorbe, 2005, European journal of gynaecological oncology.

Prognostic importance of DNA ploidy and p53 in early stages of epithelial ovarian carcinoma.

T. Seidal, I. Skirnisdottir, B. Sorbe, 2001, International journal of oncology.

Prognostic Importance of Ascites in Ovarian Carcinoma

B. Sorbe, B. Frankendal, 1983, Acta obstetricia et gynecologica Scandinavica.

A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy.

R. Henriksson, H. Hagberg, J. Nyman, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Differences in outcome for cervical cancer patients treated with or without brachytherapy.

B. Sorbe, Louise Bohr Mordhorst, A. Dreifaldt, 2017, Brachytherapy.

Radiotherapy and/or chemotherapy as adjuvant treatment of uterine sarcomas

B. Sorbe, 1985 .

Concurrent Use of PGF2α, Vibrations to the Cervix Uteri and Amniotomy to Induce Labor After Intrauterine Fetal Death

B. Sorbe, 1979, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Nuclear morphometry and DNA flow cytometry as prognostic methods for endometrial carcinoma

B. Sorbe, B. Risberg, J. Thornthwaite, 1993, International Journal of Gynecologic Cancer.

Doxorubicin-melphalan with and without cisplatin in advanced ovarian cancer--ten-year survival results from a prospective randomized study by the Swedish Cooperative Ovarian Cancer Study Group.

C. Tropé, T. Högberg, U. Stendahl, 1996, Acta oncologica.

Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapy.

T. Högberg, B. Sorbe, A. Himmelmann, 1994, European journal of cancer.

Hypermethylation of promoter regions of the APC1A and p16INK4a genes in relation to prognosis and tumor characteristics in cervical cancer patients.

S. Wingren, T. Nilsson, B. Sorbe, 2011, International journal of oncology.

Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-II.

T. Seidal, I. Skirnisdottir, B. Sorbe, 2005, International journal of oncology.

Does p53 codon 72 polymorphism have a prognostic value in carcinoma of the vulva and vagina?

B. Sorbe, M. Karlsson, G. Helenius, 2017, Medical Oncology.

Predictive and Prognostic Factors in Definition of Risk Groups in Endometrial Carcinoma

B. Sorbe, 2012, ISRN obstetrics and gynecology.

Primary aneuploid lymphoma of the uterine cervix: a case report.

P. Strang, B. Sorbe, C. Sundström, 1988, Gynecologic oncology.

Treatment of vaginal recurrences in endometrial carcinoma by high-dose-rate brachytherapy.

B. Sorbe, K. Söderström, 2013, Anticancer research.

Promoter methylation in the PTCH gene in cervical epithelial cancer and ovarian cancer tissue as studied by eight novel Pyrosequencing® assays.

S. Levanat, T. Nilsson, M. Sabol, 2011, International journal of oncology.

Prognostic impact of the expression of Hedgehog proteins in cervical carcinoma FIGO stages I-IV treated with radiotherapy or chemoradiotherapy.

C. Ahlin, B. Sorbe, Louise Bohr Mordhorst, 2014, Gynecologic oncology.

Intracavitary irradiation of endometrial carcinoma stage I by a high dose-rate afterloading technique.

B. Sorbe, B. Risberg, B. Frankendal, 1989, Gynecologic oncology.

Intracavitary irradiation of endometrial carcinomas of the uterus in stage I using a "bulb technique": physical basis.

B. Sorbe, M. Björnsson, 1982, The British journal of radiology.

Low frequency vibration dilatation of the uterine cervix.

B. Sorbe, B. Frankendal, 1979, Acta radiologica: oncology, radiation, physics, biology.

Bleomycin-Adriamycin-Cisplatin Combination Chemotherapy in the Treatment of Primary Advanced and Recurrent Cervical Carcinoma

B. Sorbe, B. Frankendal, 1984, Obstetrics and gynecology.

Antiemetic treatment of chemotherapy-induced nausea in ovarian carcinoma patients.

B. Sorbe, C. Hallén, 1989 .

Betamethasone-dixyrazine versus metoclopramide as antiemetic treatment in cancer chemotherapy.

B. Sorbe, C. Hallén, 1988, Acta oncologica.

VM‐26‐vincristine‐cisplatin combination chemotherapy in the treatment of primary advanced and recurrent endometrial carcinoma

B. Sorbe, B. Frankendal, E. Wolmesjo, 1989, Obstetrics and gynecology.

Prognostic impact of the expression of Wnt-signaling proteins in cervical carcinoma FIGO stage I-IV treated with radiotherapy or chemoradiotherapy

C. Ahlin, B. Sorbe, Louise Bohr Mordhorst, 2016, Oncotarget.

The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy

T. Seidal, I. Skirnisdottir, B. Sorbe, 2002, International Journal of Gynecologic Cancer.

HPV-negative Tumors in a Swedish Cohort of Cervical Cancer

B. Sorbe, M. Karlsson, G. Helenius, 2019, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

A study of serum biomarkers associated with relapse of cervical cancer.

C. Ahlin, B. Sorbe, Louise Bohr Mordhorst, 2012, Anticancer research.

Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma

D. Lindquist, H. Hedman, B. Sorbe, 2017, PloS one.

Whole genome expression profiling of blood cells in ovarian cancer patients -Prognostic impact of the CYP1B1, MTSS1, NCALD, and NOP14 genes

H. S. Isaksson, T. Nilsson, B. Sorbe, 2014, Oncotarget.

Prognostic Impact of p53, p27, and C-MYC on Clinicopathological Features and Outcome in Early-Stage (FIGO I-II) Epithelial Ovarian Cancer

T. Seidal, I. Skirnisdottir, B. Sorbe, 2010, International Journal of Gynecologic Cancer.

Phase II Study of Docetaxel Weekly in Combination With Carboplatin Every 3 Weeks as First-Line Chemotherapy in Stage IIB to Stage IV Epithelial Ovarian Cancer

G. Horvath, B. Sorbe, M. Graflund, 2012, International Journal of Gynecologic Cancer.

A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5‐HT3 receptor antagonist, with a metoclopramide‐containing antiemetic cocktail in the prevention of cisplatin‐induced emesis

A. V. van Oosterom, O. Hansen, T. Högberg, 1994, Cancer.

Postoperative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma stage I.

B. Sorbe, A. Smeds, 1990, International journal of radiation oncology, biology, physics.

Prognosis of endometrial carcinoma stage I in two Swedish regions. A study with special regard to the effects of intracavitary irradiation with high dose-rate afterloading technique or with low dose-rate radium.

O. Kjellgren, B. Sorbe, S. Sténson, 1990, Acta oncologica.

Postoperative vaginal irradiation by a high dose-rate afterloading technique in endometrial carcinoma stage I.

B. Sorbe, A. Smeds, Ann-Charlotte Smeds, 1990, Acta oncologica.

A Systematic Overview of Radiation Therapy Effects in Uterine Cancer (Corpus Uteri)

C. Tropé, E. Cavallin-ståhl, N. Einhorn†, 2003, Acta oncologica.

Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy

B. Sorbe, M. Karlsson, G. Helenius, 2018, Oncotarget.

A new microwave applicator with integrated cooling system for intracavitary hyperthermia of vaginal carcinoma.

M. Seegenschmiedt, B. Sorbe, G. Klautke, 1996, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas.

B. Sorbe, B. Johansson, 2008, International journal of oncology.

Betamethasone-dixyrazine combination versus high-dose metoclopramide as antiemetic treatment in doxorubicin and cisplatin chemotherapy.

B. Sorbe, I. Underskog, N. Skare, 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Randomized Trial of Single Agent Paclitaxel Given Weekly Versus Every Three Weeks and with Peroral Versus Intravenous Steroid Premedication to Patients with Ovarian Cancer Previously Treated with Platinum

U. Puistola, P. Rosenberg, B. Sorbe, 2002, Acta oncologica.

Tropisetron, a new 5-HT3 receptor antagonist, in the prevention of irradiation-induced nausea, vomiting and diarrhoea.

B. Sorbe, A. Berglind, K. D. de Bruijn, 1992, European journal of gynaecological oncology.

Natural history of recurrences in endometrial carcinoma

C. Ahlin, B. Sorbe, Christian Juresta, 2014, Oncology letters.

Prognostic importance of DNA ploidy in non-endometrioid, high-risk endometrial carcinomas.

B. Sorbe, 2016, Oncology letters.

The prognostic importance of myelosuppression in the response to chemotherapy and survival in advanced ovarian carcinoma

M. Helsing, B. Sorbe, 1987, Cancer.

Radiation treatment of laryngeal carcinoma with special reference to CRE values.

B. Sorbe, I. Underskog, J. E. Persson, 1985, Acta radiologica. Oncology.

Preoperative intrauterine irradiation of endometrial carcinoma stage I. A clinical and radiographic evaluation of the bulb technique.

B. Sorbe, S. Sténson, L. Blome, 1990, Acta oncologica.

Paclitaxel in untreated FIGO stage III suboptimally resected ovarian cancer.

C. Tropé, G. Kristensen, J. Kaern, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Combined External and Intracavitary Irradiation in Treatment of Advanced Cervical Carcinomas: Predictive Factors for Treatment Outcome and Early and Late Radiation Reactions

B. Sorbe, L. Karlsson, Louise Bohr Mordhorst, 2014, International Journal of Gynecologic Cancer.

Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences.

B. Sorbe, L. Karlsson, L. Bohr, 2009, International journal of oncology.

Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer: the Nordic experience.

A. Jacobsen, U. Puistola, C. Tropé, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Some important factors in the molding of the fetal head during vaginal delivery ‐ A photographic study

B. Sorbe, B Sorbe, S Dahlgren, 1983, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Recurrence of Ovarian Cancer-Living in Limbo

B. Ternestedt, B. Sorbe, E. Ekwall, 2007, Cancer Nursing.

A population-based series of ovarian carcinosarcomas with long-term follow-up.

B. Sorbe, S. Andersson, G. Paulsson, 2013, Anticancer research.

Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel

H. Andersson, P. Rosenberg, B. Sorbe, 2005 .

Combination chemotherapy in advanced carcinoma of the cervix

B. Sorbe, B. Frankendal, 1982, Cancer.

HPV‐DNA, vascular space invasion, and their impact on the clinical outcome in early‐stage cervical carcinomas

B. Sorbe, M. Karlsson, M. Graflund, 2004, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Primary bronchial and ovarian carcinoid tumors in the same patient: a case report and histopathologic analysis.

E. Wilander, B. Sorbe, K. Valentin, 1986, Gynecologic Oncology.

Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies.

P. Zola, A. Lissoni, S. Grénman, 2010, European journal of cancer.

Prognostic Impact of p53, p27, and C-MYC on Clinicopathological Features and Outcome in Early-Stage (FIGO I-II) Epithelial Ovarian Cancer

T. Seidal, I. Skirnisdottir, B. Sorbe, 2010, International Journal of Gynecologic Cancer.

The prognostic value of histopathologic grading parameters and microvessel density in patients with early squamous cell carcinoma of the uterine cervix.

A. Hussein, M. Bryne, B. Sorbe, 2001, International Journal of Gynecologic Cancer.

Differences in outcome for cervical cancer patients treated with or without brachytherapy.

B. Sorbe, Louise Bohr Mordhorst, A. Dreifaldt, 2017, Brachytherapy.

Women's perceptions of interactions with the health care team during treatment of the first recurrence of ovarian cancer

U. H. Graneheim, B. Ternestedt, B. Sorbe, 2009 .

Hypermethylation of promoter regions of the APC1A and p16INK4a genes in relation to prognosis and tumor characteristics in cervical cancer patients.

S. Wingren, T. Nilsson, B. Sorbe, 2011, International journal of oncology.

A comparison of external pelvic chemoradiation and high dose-rate conventional brachytherapy (BT) and image-guided adaptive brachytherapy (IGABT) in treatment of advanced cervical carcinomas

B. Sorbe, L. Karlsson, Louise Bohr Mordhorst, 2020, Archives of Women Health and Care.